🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities ! 🎄🌟 🎉
🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities ! 🎄🌟 🎉
- Welcome Guest
- Subscribe
- Login/Sign Up
Top 20: INDIA - Marginal growth
04 July 2014 | Features | By BioSpectrum Bureau
Top 20: INDIA - Marginal growth
Country Analysis for the APAC region show that India's bioscience success story received a jolt in 2013 due to regulatory and pricing issues.
The sector grew only by 3 percent. Interestingly, India too had eight companies that crossed the $1 billion mark. In fact, India's two leading companies Sun Pharma and Dr Reddy's have touched the $2 billion mark for the first time.
India announced its plan to elevate its pharma industry to touch $100 billion by 2020.
USFDA deputed training personnel to Indian state, Gujarat, to enhance quality standards of drugs exported from the state.
Â
GE Healthcare and Cancer Treatment Services International (CTSI) plans to invest $120 million in the country to develop 25 world-class centers across the country to improve cancer care over a period of 5 years.
INDIA: TOP 20 BIOSCIENCE COMPANIES
Â
